Teclistamab
Product Specifications
CAS Number
2119595-80-9
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Purity
0.95
Bioactivity
Teclistamab (JNJ-64007957) is a human bispecific monoclonal antibody targeting the CD3 receptor expressed on the surface of t-cells and the b-cell maturation antigen (BCMA) expressed on the surface of malignant multiple myeloma b-lineage cells for the treatment of relapsed and refractory multiple myeloma.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
038495-ML650 100 µL
MME, ID (MME, EPN, Neprilysin, Atriopeptidase, Common acute lymphocytic leukemia antigen, Enkephalinase, Neutral endopeptidase 24.11, Skin fibroblast elastase, CD10) (MaxLight 650) discontinued
Ask
View Details